Grace Advertising & Consulting, Inc.

accessHealth February 2022

Issue link: http://accesshealth.uberflip.com/i/1447173

Contents of this Issue

Navigation

Page 34 of 45

- 35 - accessHealthNews.net February 2022 Volume 8 | Issue No. 54 Ready to #GetTheShot? Find a vaccine near you at MOStopsCOVID.Gov T he ongoing wave of the Omicron COVID-19 variant, relaxed quarantine guidelines, and flu season are combining to create a perfect storm for a new public health concern. Flurona, a co- infection of COVID-19 and influenza, has been reported in the U.S., Israel, and Asia. According to COVID-19 and Influenza Co-Infection: A Systematic Review and Meta-Analysis, the frequency of co-infection among COVID-positive patients in the U.S. is 0.4% and expected to rise. Flurona is a combination of the two viruses and affects both upper and lower respiratory tracts and their functions, such as breathing. After the Centers for Disease Control and Prevention (CDC) shortened isolation guidelines to five days after experiencing symptoms or being asymptomatic, a growing concern has risen regarding the negative impact this may have on the already scarce workforce. Schools are taking an especially hard hit as more students, teachers, and substitute teachers demonstrate symptoms of or test positive for COVID-19 or the flu. As a result, Missouri schools are seeing administrative staff, such as principals and counselors filling in, to ensure an adult is in every classroom. As schools and businesses remain open, winter temperatures drop, and peak flu season continues, Flurona is a growing concern for community members of all ages. UNDERSTANDING FLURONA Co-infections occur when someone is infected with two or more disease-causing organisms at once. This includes the combination of two viruses or a virus and a bacterial infection. Bacterial co-infections with the influenza virus were responsible for a quarter of severe or fatal cases during the 2009 flu pandemic. Flurona, seen today, is the combination of two viruses: COVID-19 and influenza. Co-infections are common during pandemics due to shared methods of travel, among other factors. The possibility of Flurona was identified early on in the pandemic by doctors treating patients in Wuhan, China, where more than half of 307 patients hospitalized for COVID-19 also tested positive for the flu. This was determined to be the result of factors including the time of year, a localized flu outbreak, and social determinants of health affecting patients. Flurona and similar co-infections are expected to become more common in the northern hemisphere during winter and flu season due to the ongoing COVID-19 pandemic and increased frequency of "social mixing" as public mandates remain relaxed and varied. Because COVID-19 and the flu present similarly, travel similarly, and both affect breathing and other respiratory functions, it's important to get tested for and treat both viruses as soon as symptoms occur – it may not be just the flu. Both viruses are spread via droplets from breathing, coughing, and sneezing, as well as surfaces contaminated with these droplets. To best prevent Flurona, it's important to continue following COVID-19 and flu season safety guidelines, such as sanitizing hands and surfaces frequently, wearing a fitted mask around others, and socially distancing when possible.

Articles in this issue

Links on this page

view archives of Grace Advertising & Consulting, Inc. - accessHealth February 2022